Reversible Bilateral Basal Ganglia and Brainstem Lesions in Neuropsychiatric Systemic Lupus Erythematosus: A Case Report

Rocksy Fransisca V Situmeang, Reza Stevano, Ekawaty Yasinta Yohana Larope, Ratna Sutanto

Abstract


The pathophysiology behind neuropsychiatric SLE (NPSLE) remains poorly understood and its clinical and radiological manifestations are highly varied. In this report, we present a complex case of an adolescent female patient with a three-week history of systemic symptoms (fever, nausea, vomiting, weight-loss, polyarticular joint pain), progressive motor weakness, tremor, and altered mental status. Physical examination was significant for oromandibular and cervical dystonia rigidity, and general weakness with imposed right-sided hemiparesis. A head MRI demonstrated bilateral hyperintense lesions of the basal ganglia and brainstem, SS without restricted diffusion. The patient was diagnosed with NPSLE, lupus nephritis, electrolyte imbalance, severe hypoalbuminemia, lupus cardiomyopathy, autoimmune hemolytic anemia, pulmonary tuberculosis, and sepsis. The patient was given treatment in the ICU with pulse dose corticosteroids, intravenous antibiotics, intravenous immunoglobulins (IVIg), and supportive treatment with correction of hematologic and electrolyte abnormalities. Her condition improved rapidly. Full alertness was regained, and symptoms of oromandibular dystonia, tremor, and weakness diminished significantly. A follow-up MRI three weeks later revealed complete disappearance of lesions, which we attribute to resolution of the inflammatory process in the brain.


Keywords


Systemic lupus erythematosus; Neuropsychiatric lupus; Immunoglobulin therapy; Case report



DOI: http://dx.doi.org/10.19166/med.v9i3.6976

Full Text:

PDF

References


1. de Amorim JC, Frittoli RB, Pereira D, Postal M, Dertkigil SSJ, Reis F, et al. Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus. Expert Rev Clin Immunol [Internet]. 2019;15(4):407-16. https://doi.org/10.1080/1744666X.2019.1564040

2. Vivaldo JF, de Amorim JC, Julio PR, de Oliveira RJ, Appenzeller S. Definition of NPSLE: Does the ACR nomenclature still hold? Front Med. 2018;5(MAY):1-6. https://doi.org/10.3389/fmed.2018.00138

3. Monahan RC, Beaart-Van De Voorde LJJ, Steup-Beekman GM, Magro-Checa C, Huizinga TWJ, Hoekman J, et al. Neuropsychiatric symptoms in systemic lupus erythematosus: Impact on quality of life. Lupus. 2017;26(12):1252-9. https://doi.org/10.1177/0961203317694262

4. Sarbu N, Bargalló N, Cervera R. Magnetic Resonance Imaging in Neuropsychiatric Lupus. F1000Research. 2015;4(0):162. https://doi.org/10.12688/f1000research.6522.1

5. Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort [Internet]. Vol. 14, Autoimmunity Reviews. Elsevier B.V.; 2015. 153-159 p. https://doi.org/10.1016/j.autrev.2014.11.001

6. Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol [Internet]. 2014;10(6):338-47. https://doi.org/10.1038/nrrheum.2014.15

7. Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: Pathogenesis and biomarkers. Nat Rev Neurol [Internet]. 2014;10(10):579-96. https://doi.org/10.1038/nrneurol.2014.148

8. Arinuma Y, Kikuchi H, Wada T, Nagai T, Tanaka S, Oba H, et al. Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Lupus Sci Med. 2014;1(1):1-7. https://doi.org/10.1136/lupus-2014-000050

9. Zaky MR, Shaat RM, El-Bassiony SR, Abdel Razek AA, Farag SEM. Magnetic resonance imaging (MRI) brain abnormalities of neuropsychiatric systemic lupus erythematosus patients in Mansoura city: Relation to disease activity MRI brain abnormalities of neuropsychiatric systemic lupus erythematosus patients. Egypt Rheumatol. 2015;37(4):S7-11. https://doi.org/10.1016/j.ejr.2015.09.004

10. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke. 1997;28(5):1082-5. https://doi.org/10.1161/01.STR.28.5.1082

11. Hallett M, Pisani A. Neurophysiology of Dystonia: The Role of Inhibition Mark. Neurobiol Dis [Internet]. 2011;42(2):177-84. https://doi.org/10.1016/j.nbd.2010.08.025


Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Rocksy Fransisca V Situmeang, Reza Stevano, Ekawaty Yasinta Yohana Larope, Ratna Sutanto

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 

Creative Commons License

MEDICINUS is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Copyright © Fakultas Kedokteran | Universitas Pelita Harapan | Lippo Karawaci, Tangerang, Indonesia, 15811 . All rights reserved. p-ISSN 1978-3094 | e-ISSN 2622-6995